Literature DB >> 33400332

Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain.

Lara N Coughlin1,2, Mark A Ilgen1,3, Mary Jannausch1,3, Maureen A Walton1,2, Kipling M Bohnert4.   

Abstract

BACKGROUND AND AIMS: Research from cohorts of individuals with recreational cannabis use indicates that cannabis withdrawal symptoms are reported by more than 40% of those using regularly. Withdrawal symptoms are not well understood in those who use cannabis for medical purposes. Therefore, we prospectively examined the stability of withdrawal symptoms in individuals using cannabis to manage chronic pain. DESIGN, SETTING, PARTICIPANTS: Using latent class analysis (LCA) we examined baseline cannabis withdrawal to derive symptom profiles. Then, using latent transition analysis (LTA) we examined the longitudinal course of withdrawal symptoms across the time points. Exploratory analyses examined demographic and clinical characteristics predictive of withdrawal class and transitioning to more or fewer withdrawal symptoms over time. A cohort of 527 adults with chronic pain seeking medical cannabis certification or re-certification was recruited between February 2014 and June 2015. Participants were recruited from medical cannabis clinic waiting rooms in Michigan, USA. Participants were predominantly white (82%) and 49% identified as male, with an average age of 45.6 years (standard deviation = 12.8). MEASUREMENTS: Baseline, 12-month and 24-month assessments of withdrawal symptoms using the Marijuana Withdrawal Checklist-revised.
FINDINGS: A three-class LCA model including a mild (41%), moderate (34%) and severe (25%) symptom class parsimoniously represented withdrawal symptoms experienced by people using medical cannabis. Stability of withdrawal symptoms using a three-class LTA at 12 and 24 months ranged from 0.58 to 0.87, with the most stability in the mild withdrawal class. Younger age predicted greater severity and worsening of withdrawal over time.
CONCLUSIONS: Adults with chronic pain seeking medical cannabis certification or re-certification appear to experience mild to severe withdrawal symptoms. Withdrawal symptoms tend to be stable over a 2-year period, but younger age is predictive of worse symptoms and of an escalating withdrawal trajectory.
© 2021 Society for the Study of Addiction.

Entities:  

Keywords:  Cannabis use disorder; cannabis, medical cannabis; cohort; marijuana; withdrawal

Mesh:

Substances:

Year:  2021        PMID: 33400332      PMCID: PMC8363170          DOI: 10.1111/add.15370

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   7.256


  45 in total

1.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

2.  DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.

Authors:  Ofir Livne; Dvora Shmulewitz; Shaul Lev-Ran; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

3.  Use of marijuana exclusively for medical purposes.

Authors:  Melanie M Wall; Jun Liu; Deborah S Hasin; Carlos Blanco; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2018-12-04       Impact factor: 4.492

4.  Use of Marijuana for Medical Purposes Among Adults in the United States.

Authors:  Wilson M Compton; Beth Han; Arthur Hughes; Christopher M Jones; Carlos Blanco
Journal:  JAMA       Date:  2017-01-10       Impact factor: 56.272

5.  Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.

Authors:  Kenneth H Levin; Marc L Copersino; Stephen J Heishman; Fang Liu; Deanna L Kelly; Douglas L Boggs; David A Gorelick
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

6.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

7.  The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation.

Authors:  M Claire Greene; John F Kelly
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

8.  Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.

Authors:  Lewei A Lin; Mark A Ilgen; Mary Jannausch; Kipling M Bohnert
Journal:  Addict Behav       Date:  2016-05-17       Impact factor: 3.913

9.  Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers.

Authors:  Morten Hesse; Birgitte Thylstrup
Journal:  BMC Psychiatry       Date:  2013-10-12       Impact factor: 3.630

10.  Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis.

Authors:  Christian Lanz; Johan Mattsson; Umut Soydaner; Rudolf Brenneisen
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

View more
  1 in total

1.  Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice.

Authors:  Andrew J Kesner; Yolanda Mateo; Karina P Abrahao; Stephanie Ramos-Maciel; Matthew J Pava; Alexa L Gracias; Riley T Paulsen; Hartley B Carlson; David M Lovinger
Journal:  Neuropsychopharmacology       Date:  2022-04-27       Impact factor: 8.294

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.